| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Responding to Bird Flu Pandemic Readiness From Customers |
|
Useful Advices - Responding to Bird Flu Pandemic Readiness From Customers
Soon large corporate clients will be asking you if indeed you will be able to manage incase of a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Bird Flu Pandemic. They will want to know if indeed your company will still be around to supply ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in them in the event there is a Bird Flu Pandemic? What will you tell them? Are you even sure you lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ill be around? Have you got a plan? You might wish to start thinking of one now. Meanwhile here here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is a sample letter response you can send back in case you are blind sided by such a readiness in d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro uiry to such a question from a Corporate Client; Sample Response to Bird Flu Pandemic Inquiries ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Subject: Bird Flu Pandemic Readiness Thank you for your inquiry dated; (date) regarding our re easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi diness to handle a Bird Flu Pandemic has been considered and we have our plan in place, there fo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re there should be no disruptions in our services or deliver of products to your company. We re and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ognize the Bird Flu Pandemic is a serious issue, and have been working to correct the problem fo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi r (amount of time). Plans are already in place and will be completed by: (will be in place by da ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a te). We are firmly committed to providing you our product(s) and service(s) without disruption c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod used by a Bird Flu Pandemic, and (have) (will have by date) people and resources in place to add cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ress the coming of the Bird Flu Pandemic. We (are already Bird Flu Pandemic ready) (will be Bir tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Flu Pandemic ready ) in the following key areas of our business: Area __________________ Date t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Ready_________________ Example: Business Management Production planning Plant operations D ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust stribution and Delivery Please call us with any concerns or questions. ------- ------- ------- y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products - -------- -------- This should provide you with the proper timely response to the inquiry for . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de our dedication to seeing the Bird Flu Pandemic thru, but you still need to develop an outline an elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip d a plan of how you are going to deal with all a Bird Flu Pandemic. Consider all of this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Increase the Chance of a Match When Networking Outsource Network Monitoring Services To Save Working Capital
|